News
Three years after the Supreme Court overturned Roe v. Wade, abortions in the U.S. are on the rise due to provider shield laws ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
The announcement expands telehealth firms’ portfolio of branded glp-1 drugs to offer at a time when the Food and Drug Administration (FDA) is prohibiting them from selling and making compounded ...
Once someone decides they need an abortion, they will go to great lengths to get one because they know it is the right ...
The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing ...
16d
Pharmaceutical Technology on MSNNovo Nordisk teams up with WeightWatchers in latest telehealth pushThe collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
In 2022, anti-abortion groups sued to challenge a decision by the Food and Drug Administration allowing the drug to be prescribed via telehealth and sent by mail.
Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.
The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to customers. ... However, the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results